Biotech · Private company · Seattle, WA, US
Rarecyte, Inc.
Track this companyFree. Adds Rarecyte, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosisFiscal year 2026 · $658.3KNIH RePORTER 5R44CA298064-02 · fetched Nov 12, 2026
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosisFiscal year 2025 · $658.3KNIH RePORTER 1R44CA298064-01 · fetched Nov 12, 2026